Medicine Man Technologies Inc (OTCMKTS:MDCL) Director Justin Dye bought 1,500,000 shares of Medicine Man Technologies stock in a transaction on Wednesday, June 5th. The stock was acquired at an average cost of $2.00 per share, with a total value of $3,000,000.00. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Justin Dye also recently made the following trade(s):
- On Sunday, June 16th, Justin Dye bought 3,500,000 shares of Medicine Man Technologies stock. The stock was acquired at an average cost of $2.00 per share, with a total value of $7,000,000.00.
Medicine Man Technologies stock opened at $3.01 on Thursday. Medicine Man Technologies Inc has a one year low of $1.06 and a one year high of $4.17. The business has a fifty day moving average of $3.10 and a two-hundred day moving average of $2.87.
Medicine Man Technologies, Inc provides cultivation consulting services for cannabis growing technologies and methodologies. The company also provides licensing and seminar services. In addition, it engages in retail operations of cannabis products. The company was founded in 2014 and is based in Denver, Colorado.
Receive News & Ratings for Medicine Man Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicine Man Technologies and related companies with MarketBeat.com's FREE daily email newsletter.